Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT02729051 · COMPLETED
Trial details
- NCT number
- NCT02729051
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-29
- Primary completion
- 2017-05-23
- Enrollment
- 1055
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.